Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP30 | Q70CQ3 | 2/20 | 0.51 |
| ▸ | JAK2 | O60674 | 1/20 | 0.46 |
| ▸ | JAK1 | P23458 | 1/20 | 0.46 |
| ▸ | NR1D1 | P20393 | 1/20 | 0.45 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | GPR119 | Q8TDV5 | 3/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24728962 | 1.00 | USP30 (0.51) | USP30JAK2JAK1NR1D1HSD11B1 | |
| SCHEMBL19918238 | 0.85 | USP30 (0.50) | USP30JAK2JAK1NR1D1HSD11B1 | |
| SCHEMBL34473801 | 0.85 | USP30 (0.50) | USP30JAK2JAK1NR1D1HSD11B1 | |
| SCHEMBL21964124 | 0.84 | USP30 (0.47) | USP30JAK2JAK1HSD11B1HPGD | |
| SCHEMBL30776091 | 0.84 | JAK2 (0.52) | USP30JAK2JAK1NR1D1HSD11B1 | |
| SCHEMBL654162 | 0.83 | NR1D1 (0.65) | USP30JAK2JAK1NR1D1HSD11B1 | |
| SCHEMBL16105020 | 0.81 | EPHX1 (0.49) | USP30JAK2JAK1HPGDMEN1 | |
| SCHEMBL19720085 | 0.81 | USP30 (0.46) | USP30JAK2JAK1NR1D1HSD11B1 | |
| SCHEMBL2499421 | 0.80 | USP30 (0.57) | USP30JAK2JAK1HSD11B1HPGD | |
| SCHEMBL12071952 | 0.80 | USP30 (0.57) | USP30JAK2JAK1HSD11B1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250235566-A1 | TRISLINKER-CONJUGATED DIMERIC LABELING PRECURSORS AND RADIOTRACERS DERIVED THEREFROM | Medianezia GmbH (DE) | 2025-07-24 | — | — | US | disclosed |
| EP-4351663-A1 | TRISLINKER-CONJUGATED DIMERIC LABELLING PRECURSORS AND RADIOTRACERS DERIVED THEREFROM | Medianezia GmbH (DE) | 2024-04-17 | — | — | EP | disclosed |
| CN-117642190-A | Dimer-labeled precursor conjugated with a three-linker and radiotracer derived therefrom | 梅迪阿内泽有限公司 | 2024-03-01 | — | — | CN | disclosed |
| WO-2022258637-A1 | TRISLINKER-CONJUGATED DIMERIC LABELLING PRECURSORS AND RADIOTRACERS DERIVED THEREFROM | Atoms for Cure GmbH (DE) | 2022-12-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250235566-A1 | TRISLINKER-CONJUGATED DIMERIC LABELING PRECURSORS AND RADIOTRACERS DERIVED THEREFROM | TK1, TK2, TMT1A | USP30 1115/4885JAK2 2016/4885JAK1 3248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.